Sunrest Lifescience Limited (NSEI: SUNREST)
Salud · Farmacéuticas · IN
38,00 Rs
+14,98 % hoy · -15,6 % 1 año
Sunrest Lifescience Limited (NSEI: SUNREST) opera en la industria de farmacéuticas dentro del sector salud. Su valor en bolsa es de 1,75 M $ y tiene 210 empleados.
En los últimos doce meses la acción ha bajado un 15,6 % y ha cotizado entre 29,55 y 54,00.
Tweenvest puntúa a Sunrest Lifescience Limited en cuatro factores: calidad 64/100, valor 91/100, crecimiento 100/100. Su punto más fuerte es crecimiento.
Evolución de la cotización de SUNREST
Cifras clave
- Capitalización
- 1,75 M $
- Ingresos (últ. 12 m)
- 7,17 M $
- PER
- 2,07
- BPA
- 11,46
- Rent. por dividendo
- —
- Beta (5 años)
- 0,10
- Máximo 52 semanas
- 54,00 Rs
- Mínimo 52 semanas
- 29,55 Rs
- Volumen medio (3 m)
- —
- Acciones en circulación
- 4,29 M
- Empleados
- 210
- Próximos resultados
- —
Sobre Sunrest Lifescience Limited
Sunrest Lifescience Ltd. is an India-based pharmaceutical company primarily engaged in the marketing and distribution of a diverse range of healthcare and personal care products within the domestic market. The company operates on an asset-light business model, outsourcing manufacturing to third-party producers and focusing its core competencies on product selection, marketing, and distribution. Its extensive product portfolio includes both over-the-counter (OTC) and prescription-based pharmaceutical formulations, encompassing tablets, capsules, ointments, injectables, syrups, and various other forms. Sunrest Lifescience caters to numerous therapeutic segments, including anti-bacterial, anti-diabetic, anti-fungal, anti-hypertensive, analgesic, nutritional, ayurvedic, and cosmetic products. The company primarily targets consumers in India, with significant market presence and a network of distributors and retailers across states such as Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, and Orissa.
- ISIN
- INE0PLZ01012
- Fundada en
- 2017
- Cotiza desde
- 20 nov 2023
- Bolsa
- National Stock Exchange of India
- Divisa
- INR
Otras empresas de farmacéuticas
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc.NasdaqCM: SXTP | 1,82 M $ | 0,52 $ | -0,19 % |
| LIR Life Sciences Corp.CNSX: SKNY | 1,81 M $ | 0,09 CA$ | -10,00 % |
| Colinz Laboratories LimitedBSE: 531210 | 1,80 M $ | 67,50 Rs | -6,25 % |
| Hellenic Dynamics PlcLSE: HELD | 1,78 M $ | 0,01 £ | -5,26 % |
| SOHM, Inc.OTCPK: SHMN | 1,74 M $ | 0,00 $ | -20,00 % |
| Cannabis Strategic VenturesOTCPK: NUGS | 1,69 M $ | 0,00 $ | +2,44 % |
| Argent BioPharma LimitedASX: RGT | 1,68 M $ | 0,02 AU$ | +10,53 % |
| Shamrock Industrial Company LimitedBSE: 531240 | 1,65 M $ | 28,61 Rs | 0,00 % |